These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Urinary biomarkers in hydronephrosis. Madsen MG Dan Med J; 2013 Feb; 60(2):B4582. PubMed ID: 23461995 [TBL] [Abstract][Full Text] [Related]
8. Association between NDUFS1 from urinary extracellular vesicles and decreased differential renal function in children with ureteropelvic junction obstruction. Bu L; Zhang L; Wang X; Du G; Wu R; Liu W BMC Nephrol; 2024 May; 25(1):158. PubMed ID: 38720274 [TBL] [Abstract][Full Text] [Related]
18. Urinary Proteomics Yield Pathological Insights for Ureteropelvic Junction Obstruction. Froehlich JW; Kostel SA; Cho PS; Briscoe AC; Steen H; Vaezzadeh AR; Lee RS Mol Cell Proteomics; 2016 Aug; 15(8):2607-15. PubMed ID: 27215552 [TBL] [Abstract][Full Text] [Related]
19. The value of newborn urinary proteome analysis in the evaluation and management of ureteropelvic junction obstruction: a cost-effectiveness study. Mesrobian HG World J Urol; 2009 Jun; 27(3):379-83. PubMed ID: 19034461 [TBL] [Abstract][Full Text] [Related]
20. Urinary and serum biomarkers in ureteropelvic junction obstruction: a systematic review. Papachristou F; Pavlaki A; Printza N Biomarkers; 2014 Nov; 19(7):531-40. PubMed ID: 25082300 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]